vimarsana.com

Page 2 - பல்கலைக்கழகம் ஆஃப் விஸ்கான்சின் ஆரோக்கியம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Antibody Drugs For COVID-19 Are A Cumbersome Tool Against Surges

Government officials are trying to figure out how to make better use of drugs that can keep people with COVID-19 out of the hospital. That s an urgent but daunting challenge in Michigan, where hospitals are struggling to keep up with a surge in new cases. Monoclonal antibodies can hold the coronavirus in check by mimicking the body s natural immune defenses. The drugs, produced by Regeneron and Eli Lilly, can keep people with mild to moderate COVID-19 out of the hospital and have emergency authorization for people over 65, as well as others with certain underlying health conditions. On Wednesday, Michigan Gov. Gretchen Whitmer urged people in her state who qualify for these drugs to seek them out, recalling that President Trump took the treatment after he fell ill with COVID-19.

COVID-19 Antibody Drugs Are Tough To Deploy In Surges : Shots

Michigan Office of the Governor/AP hide caption toggle caption Michigan Office of the Governor/AP In an update on COVID-19 Wednesday, Michigan Gov. Gretchen Whitmer discussed the state s efforts to expand the use of monoclonal antibody therapy to help those diagnosed with COVID-19 avoid hospitalization. Michigan Office of the Governor/AP Government officials are trying to figure out how to make better use of drugs that can keep people with COVID-19 out of the hospital. That s an urgent but daunting challenge in Michigan, where hospitals are struggling to keep up with a surge in new cases. Monoclonal antibodies can hold the coronavirus in check by mimicking the body s natural immune defenses. The drugs, produced by Regeneron and Eli Lilly, can keep people with mild to moderate COVID-19 out of the hospital and have emergency authorization for people over 65, as well as others with certain underlying health conditions.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.